
Gynecomastia Procedures Market Report 2026
Global Outlook – By Procedure Type (Liposuction, Mastectomy, Thyroid Hormone Therapy, Medications, Ultrasound), By Age Group (Adolescents, Adults, Elderly), By End-User (Hospitals, Cosmetic Surgery Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Gynecomastia Procedures Market Overview
• Gynecomastia Procedures market size has reached to $1.12 billion in 2025 • Expected to grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Surge In Obesity Fueling The Growth Of The Market Due To Increasing Health Complications And Exacerbation Of The Condition • Market Trend: Innovative Non-Surgical Solutions Transforming Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Gynecomastia Procedures Market?
Gynecomastia procedures are medical treatments designed to reduce the enlargement of male breast tissue, often caused by hormonal imbalances. The purpose of these procedures is to restore a more masculine chest appearance, alleviate physical discomfort, and improve psychological well-being for individuals affected by the condition. The main types of gynecomastia procedures are liposuction, mastectomy, thyroid hormone therapy, medications, and ultrasound. Liposuction is a cosmetic surgical procedure that removes excess fat from specific areas of the body using a suction technique to contour and reshape the body. The key age groups include adolescents, adults, and the elderly, and the primary end-users are hospitals, cosmetic surgery centers, and others.
What Is The Gynecomastia Procedures Market Size and Share 2026?
The gynecomastia procedures market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing awareness of gynecomastia conditions, growth in cosmetic surgery acceptance, expansion of private cosmetic clinics, rising availability of advanced surgical tools, improved hormonal disorder diagnosis.What Is The Gynecomastia Procedures Market Growth Forecast?
The gynecomastia procedures market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for outpatient cosmetic procedures, rising use of non-invasive energy-based devices, expansion of aesthetic medicine investments, growing focus on personalized treatment planning, increasing adoption of ultrasound-assisted procedures. Major trends in the forecast period include increasing preference for minimally invasive procedures, rising demand for cosmetic male health treatments, growing adoption of advanced liposuction techniques, expansion of non-surgical treatment options, enhanced focus on patient-centric outcomes.Global Gynecomastia Procedures Market Segmentation
1) By Procedure Type: Liposuction, Mastectomy, Thyroid Hormone Therapy, Medications, Ultrasound 2) By Age Group: Adolescents, Adults, Elderly 3) By End-User: Hospitals, Cosmetic Surgery Centers, Other End-Users Subsegments: 1) By Liposuction: Tumescent Liposuction, Ultrasound-Assisted Liposuction, Power-Assisted Liposuction, Laser-Assisted Liposuction 2) By Mastectomy: Subcutaneous Mastectomy, Bilateral Mastectomy, Nipple-Sparing Mastectomy 3) By Thyroid Hormone Therapy: Synthetic Thyroid Hormones, Natural Desiccated Thyroid, Combination Therapy 4) By Medications: Anti-Estrogen Medications, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs) 5) By Ultrasound: High-Intensity Focused Ultrasound (HIFU), Low-Intensity Focused Ultrasound, Acoustic Wave TherapyWhat Is The Driver Of The Gynecomastia Procedures Market?
The increasing prevalence of obesity is expected to propel the growth of the gynecomastia procedures market going forward. Obesity refers to a medical condition characterized by excessive body fat accumulation, often measured by a body mass index (BMI) of 30 or higher, which can lead to various health complications. The rise in obesity is due to increasing sedentary lifestyles, where a lack of physical activity and prolonged sitting contribute to weight gain and poor metabolic health. Gynecomastia procedures help address the condition of enlarged male breasts, which is often exacerbated by obesity, as excess fat tissue in the chest area can mimic or worsen the appearance of gynecomastia, making surgical intervention a beneficial solution. For instance, in March 2023, according to the World Heart Foundation, a Switzerland-based non-government organization, globally around 2.3 billion adults and children are obese or overweight, and with the current obesity trend, it is estimated that the number of people living with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is driving the growth of the gynecomastia procedures industry.Key Players In The Global Gynecomastia Procedures Market
Major companies operating in the gynecomastia procedures market are Spire Healthcare Group plc, InMode Ltd., Lumenis Ltd., Cynosure LLC, Max Healthcare Institute Limited, Alma Lasers Ltd., Pristyn Care Private Limited, Cutera Inc., Solta Medical Inc., Erchonia Corporation, MicroAire Surgical Instruments LLC, Allure Medspa, Florida Plastic Surgery Group P.A., The Aesthetica, Austin Gynecomastia Center, Apyx Medical CorporationGlobal Gynecomastia Procedures Market Trends and Insights
Major companies operating in the gynecomastia procedures market are focusing on advanced innovations such as non-invasive cures to reduce surgical risks, improve patient outcomes, and address the unmet medical need for safer, more effective treatments. A non-invasive cure refers to a treatment that avoids surgery by using oral medications or external therapies to address conditions like gynecomastia without the need for incisions or anesthesia. For instance, in June 2024, BioZen Limited, a UK-based biotechnology company, introduced a groundbreaking daily pill regimen designed to cure gynecomastia. This proprietary dual-therapy formulation combines a low dose of tamoxifen (TAM) with indole-3-carbinol (I3C), a naturally occurring compound derived from cruciferous vegetables, delivered as a convenient once-daily oral medication. Preclinical data from BioZen suggest that this dual approach can holistically reverse the hormonal imbalance driving gynecomastia, potentially offering a safe, effective, and scalable alternative to surgery.What Are Latest Mergers And Acquisitions In The Gynecomastia Procedures Market?
In July 2024, Optical Express, a UK-based healthcare company, acquired Harley Medical Group for an undisclosed amount. With this acquisition, Optical Express aims to expand its multidisciplinary healthcare offerings by integrating cosmetic and dermatological services into its existing eye care operations across a broader network of locations in the UK and Europe. The Harley Medical Group is a UK-based cosmetic surgery provider specializing in procedures such as gynecomastia surgery.Regional Outlook
North America was the largest region in the gynecomastia procedures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Gynecomastia Procedures Market?
The gynecomastia procedure market consists of revenues earned by entities by providing services such as laser therapy, minimally invasive procedures, post-operative care and follow-up services, and consultation and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Gynecomastia Procedures Market Report 2026?
The gynecomastia procedures market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gynecomastia procedures industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Gynecomastia Procedures Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.21 billion |
| Revenue Forecast In 2035 | $1.62 billion |
| Growth Rate | CAGR of 7.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Procedure Type, Age Group, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Spire Healthcare Group plc, InMode Ltd., Lumenis Ltd., Cynosure LLC, Max Healthcare Institute Limited, Alma Lasers Ltd., Pristyn Care Private Limited, Cutera Inc., Solta Medical Inc., Erchonia Corporation, MicroAire Surgical Instruments LLC, Allure Medspa, Florida Plastic Surgery Group P.A., The Aesthetica, Austin Gynecomastia Center, Apyx Medical Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
